Thomas Sabia
Corporate Officer/Principal bei QUINCE THERAPEUTICS, INC.
Profil
Thomas Sabia is currently the Chief Commercial Officer at EryDel SpA and Quince Therapeutics, Inc. He has an undergraduate degree and an MBA from Salisbury State University.
Aktive Positionen von Thomas Sabia
| Unternehmen | Position | Beginn |
|---|---|---|
| QUINCE THERAPEUTICS, INC. | Corporate Officer/Principal | 01.10.2023 |
EryDel SpA
 EryDel SpA Medical SpecialtiesHealth Technology EryDel SpA offers medical research. It develops drugs and diagnostics delivered through human red blood cells via a medical device technology. The company was founded by Luigia Rossi and Mauro Magnani in 2007 and is headquartered in Bresso, Italy. | Corporate Officer/Principal | 22.02.2022 |
Ausbildung von Thomas Sabia
| Salisbury State University | Masters Business Admin |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| QUINCE THERAPEUTICS, INC. | Health Technology |
| Private Unternehmen | 1 |
|---|---|
EryDel SpA
EryDel SpA Medical SpecialtiesHealth Technology EryDel SpA offers medical research. It develops drugs and diagnostics delivered through human red blood cells via a medical device technology. The company was founded by Luigia Rossi and Mauro Magnani in 2007 and is headquartered in Bresso, Italy. | Health Technology |
